Global Clinical Outsourcing Industry Report
The number of clinical trials being outsourced is increasing and the industry is working together to develop ground-breaking partnerships that focus on creative contracting and effective oversight.
According to a recent report, more than a third of clinical trials conducted by Pharma organisations are now being outsourced to vendors and expenditure on clinical trial outsourcing has also increased with the amount of global research and development expenditure allotted to the outsourced drug developers reaching $36.6 billion last year. Whether you are a big Pharma organisation or small Biotech, the relationship between sponsor and CRO is crucial to maximise the efficiency of clinical trials.
This whitepaper gives you an up-to-date overview of the evolving nature of the outsourcing market and points to the challenges and opportunities that working with a CRO can bring. Case studies and included videos deliver industry best-practice and experiences on how to nurture and prosper from a successful relationship with your CRO.
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.